Qihan Biotech
China - Hangzhou
BiotechnologyFocus: Genome Editing Platform, Cell/Organ Transplantation Platform
Qihan Biotech is a life sciences company focused on Genome Editing Platform, Cell/Organ Transplantation Platform.
ImmunologyOncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
CD33/CLL1 dual CAR-NK cell
AML, AdultClinical Trials (1)
NCT05987696Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia
Phase 1QN-030a
AML, AdultClinical Trials (1)
NCT05665114Natural Killer(NK) Cell Therapy in r/r AML
Phase 1QN-023a
AML, AdultClinical Trials (1)
NCT05665075Natural Killer (NK) Cell Therapy Targeting CD33 in Acute Myeloid Leukemia
Phase 1QT-019B Cell Injection
Systemic Lupus Erythematosus (SLE)Clinical Trials (1)
NCT07444307A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus
Phase 1QN-019a
B-cell LymphomaClinical Trials (1)
NCT05379647Natural Killer (NK) Cell Therapy for B-Cell Malignancies
Phase 1QN-023a
AML, AdultClinical Trials (1)
NCT05601466Natural Killer(NK) Cell Therapy for Acute Myeloid Leukemia
Phase 1Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2017
Portfolio: 6 clinical trials